Related references
Note: Only part of the references are listed.A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Development of an inactivated vaccine candidate for SARS-CoV-2
Qiang Gao et al.
SCIENCE (2020)
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
Jingyou Yu et al.
SCIENCE (2020)
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi et al.
NATURE (2020)
A Thermostable mRNA Vaccine against COVID-19
Na-Na Zhang et al.
CELL (2020)
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes Interim Analysis of 2 Randomized Clinical Trials
Shengli Xia et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Feng-Cai Zhu et al.
LANCET (2020)
Transmission and prevention of SARS-CoV-2
Zhongyi Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2020)
Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques
Noe B. Mercado et al.
NATURE (2020)
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
Neeltje van Doremalen et al.
NATURE (2020)
Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay
Jianhui Nie et al.
NATURE PROTOCOLS (2020)
Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2
Jianhui Nie et al.
EMERGING MICROBES & INFECTIONS (2020)
Establishment of replication-competent vesicular stomatitis virus-based recombinant viruses suitable for SARS-CoV-2 entry and neutralization assays
Hongyue Li et al.
EMERGING MICROBES & INFECTIONS (2020)